Deciphera Pharmaceuticals Inc expected to post a loss of 58 cents a share - Earnings Preview

Deciphera Pharmaceuticals

28/10/2022 13:34

* Deciphera Pharmaceuticals Inc  DCPH.OQ   DCPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
November 3. 
    * The Waltham Massachusetts-based  company is expected to
report 
a 42.8% increase in revenue to $33.153 million from $23.22
million a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Deciphera
Pharmaceuticals
Inc is for a loss of 58 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $18​, above​ its last closing price
of $16.81. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.65       -0.66      -0.60     Beat    8.8
 Mar. 31 2022  -0.94       -0.90      -0.80     Beat    11.2
 Dec. 31 2021  -1.49       -1.38      -1.51     Missed  -9.5​
 Sep. 30 2021  -1.27       -1.28      -1.37     Missed  -7.4
 ​​Jun.        -1.16       -1.15      -1.21     Missed  -4.8
 30 2021                                                
 Mar. 31 2021  -1.07       -1.06      -1.06     Met     0.3​
 Dec. 31 2020  -1.15       -1.15      -1.10     Beat    4.5
 Sep. 30 2020  -1.31       -1.30      -1.13     Beat    13
 This summary was machine generated October 28 at 12:34 GMT.  All
figures in US dollars  unless otherwise stated